Article info
PDFHepatitis
Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy
- Correspondence to:
Professor Patrick Marcellin
Service d’Hépatologie, Hôpital Beaujon, 100 Bd du Gl Leclerc, 92110 Clichy, France; patrick.marcellin{at}bjn.ap-hop-paris.fr
Citation
Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy
Publication history
- Accepted August 30, 2006
- Revised July 24, 2006
- First published September 27, 2006.
Online issue publication
March 05, 2007
Article Versions
- Previous version (27 September 2006).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Gut